Program Saturday

Print
Please click on the relevant day to view the applicable detailed program.

Saturday, March 18
Thursday,
March 16, 2017
Friday,
March 17
HALL A
09:00-10:30 Session 11 | What next after metformin?
09:00-09:05 Chairperson: Ralph DeFronzo, USA and Pablo Ashner, Colombia
09:05-09:25 According to ALAD: Pablo Aschner, Colombia
09:25-09:45 According to American guidelines: Prioritize by individual benefits of medication: Ralph DeFronzo, USA
09:45-10:05 According to Israeli guidelines: Prioritize by individualized patient characteristics: Julio Wainstein, Israel
10:05-10:30 Discusson
HALL B
09:00-10:30 Session 12 | Bariatric and Metabolic Surgery 2016/2017
09:00-09:05 Chairperson: Guillermo González Gálvez, Mexico and Philip Home, UK
09:05-09:25 Diabetes Remission After Metabolic Surgery: Ricardo Cohen, Brazil
  Only for Obese People
09:25-09:45 Yes: Patricio Lopez-Jaramillo, Colombia
09:45-10:05 No: Philip Home, UK
10:05-10:30 Discussion
HALL C
09:00-10:30 Session 13 | Diabetic Foot
09:00-09:05 Chairperson: Edith Falcon de Legal, Paraguay and María Victoria Lavigne, Argentina
09:05-09:20 Clinical evaluation of diabetic foot: Vascular or neuropathy cause: Dong Hoon Woo, Argentina
09:20-09:35 Vascular approach, evaluation and therapy of diabetic foot: Martín Rabellino, Argentina
09:35-09:50 Diabetic foot ulcers: actual management: Javier del Vecchio, Argentina
09:50-10:05 Bioengineering for diabetic foot ulcers management: María Victoria Lavigne, Argentina
10:05-10:30 Discussion
10:30-11:00 Coffee Break
HALL A
11:00-12:30
Session 14 | Novel Insulin Analogues
11:00-11:05 Chairperson: Shlomo Vinker, Israel and Guillermo González Gálvez, Mexico
Ultra Long Acting Basal Insulin – Does Benefit Outweigh Cost?
11:05-11:20 Yes:  Baruch Itzhak, Israel
11:20-11:35 No: Philip Home, UK
11:35-11:45 Discussion
  Biosimilar in Insulin Therapy
11:45-12:00  Yes: Paolo Pozzilli, Italy
12:00-12:15 No: Guillermo González Gálvez, Mexico
12:15-12:30 Discussion
HALL B
11:00-12:30
Session 15 | Diabetes in Elderly People
11:00-11:05 Chairperson: Manuel Klein, Argentina and Alberto Zanchetti, Italy
11:05-11:25         Physiopathology of diabetes in elderly people: Carla Musso, Argentina
11:25-11:45 Therapeutic approach: Different? León Litwak, Argentina
11:45-12:10 Should blood pressure management differ in hypertensive patients with and without diabetes?  Alberto Zanchetti, Italy
12:10-12:30 Discussion
HALL C
11:00-12:30 Session 16 | Prevention of Type 2 Diabetes (T2D): Did We Fail?
11:00-11:05 Chairperson: Pascual Valdez, Argentina and Noel Barengo, Finland
  Latin America and Rest of the World
11:05-11:20 Latin America:  Juan Jose Gagliardino, Argentina
11:20-11:35 Rest of the World: Noel Barengo, Finland
11:35-11:45
Discussion
  Prevention: Lifestyle vs. Drug Therapy
11:45-12:00 Lifestyle: Martin Rodriguez, Argentina
12:00-12:15 Drug Therapy: Patricio Lopez-Jaramillo, Colombia
12:15-12:30 Discussion
12:30-13:30 Lunch Break
HALL A
13:30-15:00 Session 17 | Initial Use of Combination Therapy
13:30-13:35 Chairperson: Carla Musso, Argentina and Cristina Rondinone, USA
  Initial Combination Therapy in Type 2 Diabetes
13:35-13:50 No: Philip Home, UK
13:50-14:05  Yes:  Ralph DeFronzo, USA
14:05-14:15 Discussion
  GLP1 vs. Prandial Insulin After Basel
14:15-14:30 GLP1: Ralph DeFronzo, USA
14:30-14:45 Prandial Insulin After Basel: Rosario Arechavaleta, Mexico 
14:45-15:00 Discussion
HALL B
13:30-15:00 Session 18 | Resistant Hypertension
13:30-13:35 Chairperson: Fernando Filippini, Argentina and Alberto Zanchetti, Italy
13:35-13:55 Algorithm of assessment: Ramiro Sanchez, Argentina
13:55-14:15 Drug treatment classes: Mario Bendersky, Argentina
14:15-14:35 Denervation and barorreflex hypertension therapy system (Rheos): Agustin Ramirez, Argentina
14:35-15:00 Discussion
HALL C
13:30-15:00 Session 19 | Do we need New Trials in CV Prevention with Antihyperglycemic Drugs?
13:30-13:35 Chairperson: Isaac Sinay, Argentina and Paolo Pozzilli, Italy
13:35-13:50 Interaction brain/metabolisim. How diabetes induces neuro-degeneration: Sandra Rojas, Germany
13:50-14:05 Lipid Lowering Trials: Eduardo O. Esteban, Argentina
14:05-14:20  DPP4's: Itamar Raz, Israel
14:20-14:35 SGLT2: Paolo Pozzilli, Italy
14:35-15:00  Discussion
15:00-15:30 Coffee Break
HALL A
15:30-16:30 Session 20 | Present and Future Strategies to Keep Patients on Target
15:30-15:35 Chairperson:  Shlomo Vinker, Israel 
15:35-15:50 Diabetes: Pablo Aschner, Colombia
15:50-16:05 Obesity: Luc Van Gaal, Belgium
16:05-16:20 Hypertension: Ramiro Sanchez, Argentina
16:20-16:30 Discussion
HALL B
15:30-16:30 Session 21 | Meet the Experts
15:30-15:35 Chairperson: Edith Falcon de Legal, Paraguay
15:35-15:55 The future of medicines for diabetes: Beyond glucose lowering: Cristina Rondinone, USA
15:55-16:15 The need for a cardio-renal-metabolic approach to the patient with diabetes: Danilo Verge, USA
16:15-16:30 Discussion
HALL C
15:30-16:30 Session 22 | Meet the Expert
15:30-15:35 Chairperson: Agustin Ramírez, Argentina
15:35-16:15 New target in hypertension: what blood pressure has been measured in SPRINT? : Alberto Zanchetti, Italy
16:!5-16:30 Discussion
   
HALL A
16:30-16:50 Closing Ceremony 
Chairpersons: Leon E. Litwak, Argentina, Carla Musso, Argentina and Itamar Raz, Israel